日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Roads and detours for CAR T cell therapy in autoimmune diseases

CAR-T细胞疗法在自身免疫性疾病治疗中的道路和弯路

Avouac, Jérôme; Barzel, Adi; Caiati, Delma; Davis, Randall S; Gottschalk, Stephen; Grieshaber-Bouyer, Ricardo; Mao, Xuming; Luning Prak, Eline T; Radic, Marko; Scherlinger, Marc; Suneja, Yatin; Talleur, Aimee; Thacker, Amber L; Unutmaz, Derya

BACH2 regulates T cell lineage state to enhance CAR T cell function

BACH2通过调控T细胞谱系状态来增强CAR T细胞功能

Chang, Tien-Ching; Heard, Amanda; Lattin, John; Warrington, John M; Barrett, Amanda; Landmann, Jack H; Tenzin, Yangdon; Ganesh, Vishaal; Thompson, Bryant; Afrin, Sadia; Gupta, Deepesh Kumar; Chang, Ju-Fang; Ritchey, Julie; Selli, Mehmet Emrah; Hsu, Yu-Sung; Song, Haorui; Federico, A J; Horn, Avery; Meers, Michael P; Weber, Evan W; Wandless, Thomas J; Crawford, Jeremy Chase; Thomas, Paul G; DiPersio, John F; Gottschalk, Stephen; Singh, Nathan

Cell therapy for brain tumors: The first 60 years

脑肿瘤细胞疗法:前60年

Mehta, Sanya; Krenciute, Giedre; Gottschalk, Stephen

LRRC15-CAR T Cells for the Treatment of Osteosarcoma.

LRRC15-CAR T 细胞用于治疗骨肉瘤。

O'Reilly Carla, Tuladhar Shraddha, Nguyen Phuong, Sheppard Heather, Koo Selene C, Chockley Peter, Houke Haley, Santiago Teresa, Tian Liqing, Jeschke Julie, Beckett Alex N, Chabot Ashley, Yustein Jason, Krenciute Giedre, Talbot Lindsay J, Gottschalk Stephen, DeRenzo Christopher

Reprogramming CAR T-Cells with designed bioPROTACs

利用设计的生物PROTAC对CAR T细胞进行重编程

Peche, Vivek S; Kenny, Sebastian; Kang, Tae Gun; Coventry, Brian; Mi, Tian; Goreshnik, Inna; Sanchez, Mariana Garcia; Martin, Reid; Smith, Macey; Vafeados, Dionne; Kathayat, Rahul S; Kaiwen, Yu; Yuan, Zuo-Fei; Wu, Long; High, Anthony; Nemecek, Andrew; Wickmann, Elizabeth; Adeshakin, Adeleye; Ferrara, Francesca; Throm, Robert E; Chen, Taosheng; Youngblood, Benjamin; Baker, David; Gottschalk, Stephen

Antigen Specificity and Cell Engineering Determine CAR T Cell Efficacy in Group 3 Medulloblastoma.

抗原特异性和细胞工程决定了 CAR T 细胞在 3 组髓母细胞瘤中的疗效。

Krenciute Giedre, Ward Meghan, Fouliard Justine, Meehl Michaela, Dinh Diana, Ibanez-Vega Jorge, Liu Jingjing, Roussel Martine, Yu Jiyang, Gottschalk Stephen

Preclinical development of lentiviral vector gene therapy for Diamond-Blackfan anemia syndrome.

针对Diamond-Blackfan贫血综合征的慢病毒载体基因疗法的临床前开发

Bhoopalan Senthil Velan, Mayuranathan Thiyagaraj, Liu Nana, Mayberry Kalin, Yao Yu, Zhang Jingjing, Métais Jean-Yves, Yan Koon-Kiu, Throm Robert E, Ellis Steven R, Ju Yan, Han Lei, Suryaprakash Shruthi, Palmer Lance E, Zhou Sheng, Yu Jiyang, Cheng Yong, Yen Jonathan S, Gottschalk Stephen, Weiss Mitchell J

EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapy

EASIX 和 m-EASIX 可预测 CD19-CAR T 细胞治疗后儿童和青少年患者的 CRS 和 ICANS 发生率

Zandaki, Dua'a; Selukar, Subodh; Bi, Yu; Li, Ying; Zinsky, Megan; Bonifant, Challice L; Epperly, Rebecca; Keerthi, Dinesh; Triplett, Brandon M; Gottschalk, Stephen; Naik, Swati; Talleur, Aimee C

Age-adjusted dosing of fludarabine for lymphodepletion in CAR T-cell therapy: a clinical trial simulation study

CAR-T细胞疗法中用于淋巴清除的氟达拉滨年龄调整剂量:一项临床试验模拟研究

Panetta, John C; Talleur, Aimee C; Naik, Swati; Gottschalk, Stephen; Leggas, Markos

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

急性髓系白血病CAR-T细胞临床试验的开展和报告国际共识指南

Naik, Swati; Aplenc, Richard; Baumeister, Susanne H C; Becilli, Marco; Bhagwat, Anand S; Bonifant, Challice L; Budde, Lihua E; Chien, Christopher D; Curran, Kevin J; Daniyan, Anthony F; Dreyzin, Alexandra; Gardner, Rebecca A; Ghorashian, Sara; Gottschalk, Stephen; Hill, LaQuisa C; Kohler, M Eric; Lamble, Adam; Locatelli, Franco; Mamonkin, Maksim; Omer, Bilal; Park, Jae H; Quintarelli, Concetta; Rambaldi, Benedetta; Richards, Rebecca M; Sallman, David A; Sauer, Tim; Shah, Nirali N; Subklewe, Marion; Summers, Corinne; Tasian, Sarah K; Taylor, Naomi; Tettamanti, Sarah; Verneris, Michael R; Velasquez, M Paulina; Gill, Saar I